Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Viragen Inc
Original Assignee
Viragen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viragen IncfiledCriticalViragen Inc
Priority claimed from EP84102404Aexternal-prioritypatent/EP0153969B1/en
Application grantedgrantedCritical
Publication of DE3485059D1publicationCriticalpatent/DE3485059D1/en
Pref. the vehicle is a non-toxic lyophilic base and the transfer factor is present in amt. up to 10 units per gram of compsn. (10 power 8 cells per unit). Pref. the compsn. further includes an enhancing penetrant chosen from dimethylsulphoxide and/or low mol.wt. dextran. Esp. the penetrant is DMSO present in amt. 1-15 wt.%. The compsn. may be used for cosmetic purposes and for treatment of skin lesions.
DE8484102404T1984-03-061984-03-06
MEDIUM FOR TREATMENT WITH TRANSFER FACTOR.
Expired - Fee RelatedDE3485059D1
(en)
2,6-C-DIMETHYLTYROSINE1- (D-AMINO-ACID) 2- (E-AMINO-CAPROIC ACID AND G-AMINOBUTYRIC ACID) 5 OF METHIONINE-ENCEPHALIN, SUITABLE IN PARTICULAR AS ANALGESICS